Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Ken Kato

National Cancer Center Hospital, Tokyo


Dr Ken Kato is a medical oncologist. His primary interest is chemotherapy and chemoradiotherapy for oesophageal, esophagogastric, and gastric cancer. Chief of Department of Head and Neck, and Esophageal medical oncology, and Gastrointestinal Medical Oncology, National Cancer Center Hospital, 2020-2022. Chief, Biobank Translational Research Support Section, Clinical Research Coordinating Section, Clinical Research Support Office, National Cancer Center Hospital. He is a group coordinator of the Japan Esophageal Oncology Group of JCOG, the biggest clinical trial group for cancer in Japan.

He and his group have conducted clinical trials to develop new chemotherapy for metastatic disease and early oesophageal cancer in multimodality therapy. As a study coordinator, he has conducted the randomized phase III trial, which compared the surgery and chemoradiotherapy for clinical stage I oesophageal squamous carcinoma, named JCOG0502, which reported the non-inferiority of chemoradiotherapy to surgery. He and his group conducted the randomized phase III trial of neoadjuvant therapy for resectable oesophageal squamous cell carcinoma, named JCOG1109.

He also committed to the international phase III trial of oesophageal and gastric cancer with an immune-checkpoint inhibitor.

His research interest is to develop a new combination of therapy and translational research to improve the outcomes of oesophageal cancer patients.

Last update: April 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.